Organometallic small molecule kinase inhibitors - direct incorporation of Re and 99mTc into Opaganib®.
Ontology highlight
ABSTRACT: [(η5-Cp)ReI(CO)3] was incorporated into the kinase inhibitor Opaganib®. The resulting bioorganometallic complex showed a similar anti-cancer activity to Opaganib® against PC-3 cancer cells. The IC50 value for the kinase SK2 is 30x higher than that of Opaganib®. The 99mTc homologue was synthesized, completing a matched-pair for molecular theranostics.
SUBMITTER: Lengacher R
PROVIDER: S-EPMC8658909 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA